Yes, VAS can still be distributed in areas where there is limited access to COVID-19 testing. The GAVA guide recommends that screening be conducted prior to VAS administration, allowing for additional infection prevention and control (IPC) measures to be put in place to protect health workers from infection. Furthermore, the IPC measures described in the GAVA guide are meant to reduce the risk of COVID-19 transmission between health workers and community members and within communities, understanding that screening may not be sensitive enough to detect all cases.